Skip to main content

Connor, Clark & Lunn Investment Management Ltd.

Position in NVCR — NovoCure Ltd

CIK 1596800 VANCOUVER, A1

Position in NVCR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$10,018,391
+$2,208,116 QoQ
Shares Held
661,280
-7.7% QoQ
Ownership
0.568%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#32
of 214 holders
Holding Since
Jun 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVCR Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $204,731,115 across 26 Medical Devices names. NVCR ranks #5 (4.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 NVCR
NovoCure Ltd
This page
661,280 $10,018,391

All Filings in NVCR

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,018,391 661,280
2026-03-31 $7,810,275 716,539
2025-12-31 $8,550,570 661,297
2025-09-30 $7,293,378 564,503
2025-06-30 $10,870,709 610,714
2025-03-31 $9,529,227 534,749
2024-12-31 $13,045,605 437,772
2024-09-30 $6,662,490 426,263
2024-06-30 $6,280,800 366,655
2024-03-31 $4,913,712 314,377
2023-12-31 $6,115,328 409,600
2023-09-30 $6,602,749 408,839
2023-06-30 $2,873,003 69,229
2023-03-31 $556,355 9,251
2022-06-30 $886,125 12,750